Vilin Bio Med Stock Screener | Share Price & Fundamental Analysis

VILINBIO Pharmaceuticals
Screen Vilin Bio Med share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap ₹28.25 Cr.
P/E Ratio (TTM) 15.00
P/B Ratio 1.22
EPS (TTM) ₹0.16
Dividend Yield -
Debt to Equity 0.20
52W High -
52W Low -
Operating Margin 8.00%
Profit Margin 12.50%
Revenue (TTM) ₹8.00
EBITDA ₹2.00
Net Income ₹1.00
Total Assets ₹28.00
Total Equity ₹23.00
Last updated: Jan 10, 2026

Vilin Bio Med Share Price History - Stock Screener Chart

Screen VILINBIO historical share price movements with interactive charts. Analyze price trends and patterns.

Vilin Bio Med Company Profile - Fundamental Screener

Screen Vilin Bio Med company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VILINBIO shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE0L4V01013

Vilin Bio Med Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen VILINBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020
Assets
Total Assets 28 32 18 14 14 14
Current Assets 13 19 8 12 12 12
Fixed Assets 1 1 2 2 2 2
Liabilities
Total Liabilities 28 32 18 14 14 14
Current Liabilities 0 0 1 1 1 0
Non-Current Liabilities 0 0 0 0 0 0
Shareholders' Equity
Total Equity 23 23 11 7 7 7
Share Capital 14 14 10 3 3 3
Reserves & Surplus 9 9 1 4 4 4

Vilin Bio Med Income Statement Screener - Profit & Revenue Analysis

Intrinsic Value
Screen VILINBIO income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March
Revenue 8 15 16 12 11 12 17
Expenses 7 14 15 10 10 11 16
EBITDA 2 1 1 3 1 1 1
Operating Profit % 8.00% 5.00% 5.00% 21.00% 7.00% 7.00% 5.00%
Depreciation 0 0 0 0 0 0 0
Interest 0 1 1 1 1 0 0
Profit Before Tax 1 0 0 2 0 0 0
Tax 0 0 0 1 0 0 0
Net Profit 1 0 0 1 0 0 0
EPS 2.20 0.16 0.12 1.25 0.10 0.15 0.20

Vilin Bio Med Cash Flow Screener - Liquidity Fundamentals

Screen VILINBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March
Operating Activities 0 -7 -2 0 -1 -2
Investing Activities -1 0 0 0 0 0
Financing Activities -5 9 2 0 1 2
Net Cash Flow -6 2 0 0 0 0

Vilin Bio Med Shareholding Pattern Screener - Ownership Analysis

Screen VILINBIO shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Sept 2023-Jun 2023-Sept
Promoter Holding 63.89% 63.89% 63.89% 64.52% 64.09% 90.45% 64.52%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 34.18% 33.49% 33.55% 33.84% 34.47% 9.45% 32.80%
Other Holding 1.94% 2.62% 2.57% 1.65% 1.45% 0.10% 2.68%
Shareholder Count 551 492 476 585 581 827 659

Vilin Bio Med Dividend Screener - Share Yield Analysis

Screen VILINBIO dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
No dividends declared by Vilin Bio Med.

Vilin Bio Med Index Membership - Market Screener Classification

Screen VILINBIO by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Vilin Bio Med is not part of any tracked indices.
Only major market indices are tracked in our system.

Vilin Bio Med Market Events Screener - Corporate Actions

Screen VILINBIO market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -4.24%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -5.85%
2025-05-17 2025-05-17 Quarterly Result Announcement NA 4.73%
2024-10-30 2024-10-30 Quarterly Result Announcement NA -6.15%

Vilin Bio Med Competitors Screener - Peer Comparison

Screen VILINBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 416,764 40.16 54,729 9.71% 10,980 41.99
Divis Laboratories 172,462 69.16 9,712 18.67% 2,191 54.95
Torrent Pharmaceuticals 129,770 60.40 11,539 6.99% 1,911 64.03
Cipla 120,864 22.30 28,410 7.12% 5,291 43.36
Dr Reddys Laboratories 105,645 18.66 33,741 16.73% 5,725 50.22
Lupin 96,238 22.21 22,910 13.74% 3,306 58.72
Zydus Life Science 92,352 18.57 23,511 18.55% 4,615 41.66
Mankind Pharma 90,530 51.90 12,744 20.90% 2,007 47.28
Aurobindo Pharma 70,358 20.66 32,346 9.43% 3,484 55.09
Alkem Laboratories 66,550 27.75 13,458 3.70% 2,216 44.89

Vilin Bio Med Company Announcements - News Screener

Screen VILINBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.

No company announcements available.

Back to Screener